Submitted by Anonymous (not verified) on 30 November 2023 - 16:23
Human medicines European public assessment report (EPAR): Rubraca, rucaparib, Ovarian Neoplasms, Date of authorisation: 23/05/2018, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rubraca, rucaparib, Ovarian Neoplasms, Date of authorisation: 23/05/2018, Revision: 15, Status: Authorised